跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PALANDRA ED ethinylestradiol 30 micrograms / drospirenone 3 mg film coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PALANDRA ED ethinylestradiol 30 micrograms / drospirenone 3 mg film coated tablet blister pack
Approved
STANDARD
PALANDRA ED ethinylestradiol 30 micrograms / drospirenone 3 mg film coated tablet blister pack
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
bc9b7e5a0d2debc4
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
bc9b7e5a0d2debc4
Product Name
PALANDRA ED ethinylestradiol 30 micrograms / drospirenone 3 mg film coated tablet blister pack
Artg Id
226239
Artg Name
PALANDRA ED ethinylestradiol 30 micrograms / drospirenone 3 mg film coated tablet blister pack
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2014-08-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
bc9b7e5a0d2debc4
Type
Standard
Back to TGA Approvals